Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (3)
Active Filters (3)
Clear All
1 - 12 of 54 Results
Sort by:
Best Match
Flyer
The T-SPOT.CMV test assesses a patient’s level of anti-CMV cell-mediated immunity
Explore how Cytomegalovirus (CMV) cell-mediated immunity and the T-SPOT.CMV test can enhance understanding of CMV immune status, crucial for managing patients at risk of disease after organ and stem cell transplants.
Whitepaper
How CRISPR-based functional genomics is transforming drug discovery
Exploring how functional genomics is used in preclinical drug discovery with target identification, drug response mechanisms, and in vivo tumor biology.
Flyer
Auto-Pure 2400 for use with T-SPOT.TB: Efficient workflow, more time for you
The Auto-Pure 2400 can perform day 1 T-SPOT.TB workflows in under 3.5 hours with a single mid-run user interaction.
Scientific Poster
Illuminating the path to innovation: Revvity's high content screening services
This scientific poster presented at ELRIG Drug Discovery introduces Revvity's preclinical high content imaging services.
Form
Investigator Led Study Form
Are you a researcher with an exciting research proposal in infectious disease diagnostics or life sciences? Discover how our Investigator Led Studies program can help bring your innovative research to life with Revvity's support!
Infographic
Uncover the Global Tuberculosis (TB) Landscape
Download our exclusive infographic on the global TB landscape. Explore key insights on diagnostics, prevention, and elimination strategies. Join the fight against TB.
Application Note
Effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in high-content analysis screening experiments
Find out about the effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in HCA screening experiments.
Application Note
Pooled phenotypic CRISPR screening enables the identification of synergistic drug combinations for cancer therapy
This application note demonstrates how a pooled phenotypic CRISPR screening can be used to identify synergistic drug combinations for cancer therapy
Literature - Publication Review
Linking genes to phenotypes with CRISPR screening
Literature review on the multiple CRIPSR screening techniques available for drug discovery and their benefits.
Whitepaper
Overcoming hurdles in high-throughput profiling of cancer cell responses
Presenting case studies on how functional genomic screening is used to find therapeutic targets, identify patient populations, uncover MoA, investigate drug combinations, and reveal drug resistance and sensitivity
Whitepaper
CRISPR-Cas9 screening: a powerful approach to advance drug discovery
Find out about the potential of CRISPR-Cas9 screening for drug discovery in this white paper.
Webinar
wbs-leveraging-multiplatform-cell-based-screening-for-target-id
Learn about how to leverage multiplatform cell-based screening for target ID in this on-demand webinar.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.